Pharmacokinetic Profiling of Pembrolizumab and Nivolumab in Patients With Melanoma and/or Non-Small Cell Lung Cancer
Clinical trial NCT05740501 · COMPLETED
Trial details
- NCT number
- NCT05740501
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-04-26
- Primary completion
- 2020-01-03
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.